semaglutide vision problems New study links Ozempic to loss Ozempic Vision Loss: What Patients

There are multiple ongoing oppositions against other semaglutide use patents, including EP3448416 for cardiovascular indications

La Semaglutida ya es conocida en su forma inyectable, pero esta nueva formulacin oral marca un antes y un despus en el tratamiento de la diabetes

The researchers acknowledged study limitations, including possible outcome misclassification because of the use of diagnostic codes not validated in claims data, potential underrecording of GI adverse events in the claims databases, and not being able to rule out possible residual confounders from certain factors like BMI

Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population